Congestive Heart Failure News and Research

RSS
Congestive Heart Failure is a condition in which the heart can't pump blood the way it should. In some cases, the heart can't fill with enough blood. In other cases, the heart can't send blood to the rest of the body with enough force. Some people have both problems. "Heart failure" doesn't mean that your heart has stopped or is about to stop working. However, it's a serious condition that requires medical care. Heart failure develops over time as the pumping of the heart grows weaker. It can affect the right side of the heart only or both the left and right sides of the heart. Most cases involve both sides of the heart.
CTI announces positive results from Phase I-II pixantrone combination study against INHL

CTI announces positive results from Phase I-II pixantrone combination study against INHL

CerebralRx launches FitNeS vagus nerve stimulation system for treating epilepsy

CerebralRx launches FitNeS vagus nerve stimulation system for treating epilepsy

Response Biomedical NTproBNP Assay does not meet FDA regulatory criteria for CLIA waiver

Response Biomedical NTproBNP Assay does not meet FDA regulatory criteria for CLIA waiver

Servier, Cortex sign new option agreement for AMPAKINE technology

Servier, Cortex sign new option agreement for AMPAKINE technology

Unique approach improves discharge disposition and older patient's outcomes

Unique approach improves discharge disposition and older patient's outcomes

Thymosin beta 4 can transform adult epicardial stem cells into functional heart muscle

Thymosin beta 4 can transform adult epicardial stem cells into functional heart muscle

Gleevec shows significant overall survival benefit for patients w/ GIST after 3 years of adjuvant treatment vs. 1 year

Gleevec shows significant overall survival benefit for patients w/ GIST after 3 years of adjuvant treatment vs. 1 year

Older adults with subclinical hyperthyroidism may face higher risk of dying

Older adults with subclinical hyperthyroidism may face higher risk of dying

KGI scientists identify new gene regulator that keeps hearts healthy even under intense exercise

KGI scientists identify new gene regulator that keeps hearts healthy even under intense exercise

NovaShunt launches new corporate identity and product branding

NovaShunt launches new corporate identity and product branding

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

Eplerenone reduces new onset atrial fibrillation and flutter in patients with class 2 heart failure

Eplerenone reduces new onset atrial fibrillation and flutter in patients with class 2 heart failure

The Chartis Group and HPMG partner to help providers improve outpatient care delivery systems

The Chartis Group and HPMG partner to help providers improve outpatient care delivery systems

Pfizer's axitinib Phase 3 trial in advanced renal cell carcinoma meets primary endpoints

Pfizer's axitinib Phase 3 trial in advanced renal cell carcinoma meets primary endpoints

Response Biomedical first quarter total revenues increase 59% to $2,470,560

Response Biomedical first quarter total revenues increase 59% to $2,470,560

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

Frequently hospitalized patients may need a specialist focused on their care: Hospital care expert

Frequently hospitalized patients may need a specialist focused on their care: Hospital care expert

New study identifies less invasive therapy for ACE inhibitor side-effects

New study identifies less invasive therapy for ACE inhibitor side-effects

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Nursing environment linked to improved patient outcomes

Nursing environment linked to improved patient outcomes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.